Search for company

Lupin Ltd. (India)

Quote Chart
Quote Summary
Last Price 1,814.65
Volume 41,460
Turnover 76,107,086
Index    CNX 100
Market Bombay Stock Exchange
Ticker 500257
Market Cap Market Cap 817,312,197
52 Week High 2,107.05
52 Week Low 1,376.50
P/E 34.01
EPS 53.4
Dividend Yield 3.2 (March 31, 2012)
Bookvalue 126,658,600
Enterprise Value 904,018,492
Quote updated on November 27, 2015
Note: data in INR Thousands.
Select Items to chart them. 2016 Q2
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets N/A
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: Dion Global Solutions Limited, EMIS Company Database.
Company Description

Lupin Ltd. commenced business in the year 1968 to venture as a Transnational Pharmaceutical Company. The Company develops and markets a wide range of generic and branded formulations and APIs for the developed and developing markets of the world. The company's office is located in Mumbai.

Main Products

Capsules, Inhalers, Liquids (Injectables), Liquids (Formulations), Injectibles (Liquid), Creams & Powders, Injectible Vials, Tablets, Bulk Drugs (Intermediates),

Contact Information

Legal Address
159, C.S.T Road,, Kalina, Santacruz (East)
Mumbai; Maharashtra; Map
Postal Code: 400098
Tel: 66402323
Fax: 26528806

Full name: Lupin Ltd.

Previous name(s): LUPIN CHEMICALS LTD (1983)

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: L24100MH1983PLC029442
ISIN Code: INE326A01029
Incorporation Date: 1983

Basic Information
Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
2012: Imports INR 7,301,500.00 Thousands
Import connections ('000)
2012: Exports INR 30,329,200.00 Thousands
Export connections ('000)
Key Executives
Ownership Details
Indian Promoters
Affiliates and related companies
Lupin Atlantis Holdings SA
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - India

Register Your Interest

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.